Consumer telehealth · Weight-care / GLP-1
Found
Found is a direct-to-consumer telehealth company focused on weight and metabolic care. Clinicians review patients online and medications ship through pharmacy partners when prescribed. Compounded medications are not FDA-approved finished drugs.
Strong fit
- People who want weight care led by a clinician, with insurance options where available
- Patients comparing GLP-1 and non-GLP-1 medications, with ongoing check-ins
- Buyers who understand that compounded medications are not FDA-approved finished drugs
Weak fit
- Patients who need in-person obesity specialists and local procedures
- Anyone unwilling to check pharmacy partners and clinician credentials
- Buyers looking for clinical software for providers
Bottom line
Found is worth using for adults who want weight and metabolic care online, including GLP-1 options, with clinician review and home delivery. It suits people who value easy access and a clear membership price. People who want ongoing care from a local obesity clinic should look elsewhere.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Found is a consumer telehealth company focused on weight and metabolic care. Its programs center on weight management, including GLP-1 options.
Patients fill out an online health form, meet a clinician, and get medications through partner pharmacies when prescribed.
For patients, the benefit is access and convenience more than the ongoing care of a specialty clinic. Price and access are the usual reasons people choose it.
As with similar companies, compounded products are not FDA-approved finished drugs, so patients should check the partner pharmacies. Pricing combines a membership with medication costs and is more open than many enterprise tools.
Among consumer telehealth companies we review, Found scores above Henry Meds, close to AgelessRx, and below Pepti, which has a broader specialty medication offering.
Competitor landscape
| Vendor | Overall | Ease of use |
|---|---|---|
| Allara Health | 7.7 | 7.8 |
| Form Health | 7.5 | 7.3 |
| Found | 7.4 | 7.2 |
| Calibrate | 7.3 | 7.1 |
| Eden | 7.3 | 7.2 |
| Fridays | 7.1 | 7.0 |
| Mochi Health | 7.0 | 6.6 |
| Nu Image Medical | 6.8 | 6.5 |
| Sesame | 6.8 | 6.7 |
| Henry Meds | 6.7 | 6.3 |
| GobyMeds | 6.6 | 6.5 |
Pricing
| Item | Detail |
|---|---|
| Model | A membership plus medication. Visits are cash-pay, with some insurance coverage depending on your plan and state. |
| What usually drives cost | Which medication you take (brand-name or compounded), dose increases, membership length, and insurance coverage for visits. |
| What to ask before you buy | The full monthly cost at your likely dose, what happens at refill, and which pharmacy fills the prescription. |
| Published pricing | Found posts promotional starting prices for membership and medication on joinfound.com. Confirm the total at checkout. |
Compounded GLP-1 products are not FDA-approved finished drugs. Confirm current offerings and pharmacy partners.
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Found to function | |
| A willingness to fill out an honest health history | Clinicians cannot prescribe safely on incomplete history. |
| An understanding that compounded drugs are not FDA-approved finished drugs | This applies to many consumer medication programs. |
| A shipping address and ability to receive packages | Delivery fails when no one can receive packages. |
| Living in a state where it can prescribe by telehealth | Licensed providers must cover your state. |
| Budget for membership plus medication over months | Raising the dose takes months, not a week. |
| What will maximize your value | |
| Track side effects and message the care team early | Ignored symptoms become emergency visits. |
| Compare the full monthly cost after promotions end | The intro price is not the ongoing price. |
| Confirm which pharmacy fills your prescription | A change of pharmacy changes your experience. |
| Keep your primary clinician informed | Split care creates safety gaps. |
| Review your goals at each dose change | Auto-refills without check-ins waste money. |
| Deal-breakers | |
| Your main treatment needs to be in-person procedures from a specialist. | |
| You refuse to review clinicians and pharmacy partners. | |
| You want only FDA-approved finished drugs and the program cannot meet that. | |
| You are looking for EHR software, not a consumer program. | |
| You cannot receive or pay for ongoing medication shipments. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | From sign-up to clinician review | Usually days, sometimes about a week depending on labs and state |
| 2 | From clinician review to first shipment | Several days to a couple of weeks depending on pharmacy and meds |
| 3 | From first shipment to a steady routine | 4-12 weeks of dose changes and check-ins before a steady schedule |
Leadership
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.